What happened
Novel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validation
SourceElsevier BVpublicationBiotech
Novel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validation
Publication signal: Novel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validation
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceElsevier BVLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceElsevier BVLinked output
Novel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validationpaperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Novel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validation
Novel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validation
Protein and Drug Design
Controlled AISci Stage A topic for Protein and Drug Design.
Timeline
- publicationNovel 4-(pyrimidin-5-yl)benzaldehyde based α-acyloxy amides via optimized Passerini reaction: In vitro COX inhibition and computational validation